Riskpilot← Back to searchSign inGet full accessNorpa AB
ABActiveOrg 5564754199Mjörn Röd 22General medical practice activities · NACE 8621Est. 19930 employees
Revenue 2024
SEK 1,4M
+6% vs 2023
EBITDA margin
93.4%
+17% vs 2023
Equity ratio
56.9%
Financial strength
Net profit 2024
SEK -8K
-101% vs 2023
| Revenue | SEK 1,4M | +6% |
| EBITDA | SEK 1,3M | +17% |
| Net profit | SEK -8K | -101% |
| Total assets | SEK 4,5M | +0% |
| Equity | SEK 2,5M | -18% |
| Employees | 0 | — |
Legal name
Norpa AB
Org number
5564754199
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 november 1993
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Brune, Lars Tage Oscar
Company purpose
Bolaget ska utföra byggnation, förvaltning och ägande av fast egendom samt därmed förenlig verksamhet.
Address
Mjörn Röd 22
Email
elisabeth.watsfeldt@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 166 | 1 167 | 1 202 | 1 340 | 1 427 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 055 | 1 041 | 1 152 | 1 135 | 1 333 |
| Depreciation & amort. | −245 | −245 | −245 | −293 | −439 |
| EBIT | 810 | 796 | 907 | 842 | 894 |
| Net financials | — | 1 | — | 23 | 18 |
| Profit before tax | 810 | 797 | 907 | 865 | −8 |
| Tax | −0 | −59 | −187 | −178 | −0 |
| Net profit | 810 | 738 | 720 | 687 | −8 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 968 | 4 801 | 4 675 | 4 485 | 4 479 |
| Equity | 3 960 | 3 698 | 3 418 | 3 105 | 2 547 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 008 | 1 103 | 1 257 | 1 380 | 1 932 |
| Total debt | 1 008 | 1 103 | 1 257 | 1 380 | 1 932 |
EBITDA margin
93.4%
This company
15.8%
Market median
+491% vs market
20202024
Equity ratio
56.9%
This company
38.2%
Market median
+49% vs market
20202024
Return on equity
-0.3%
This company
18.4%
Market median
-102% vs market
20202024
Net profit margin
-0.6%
This company
8.1%
Market median
-107% vs market
20202024
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
20202024
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EG Chief Auditor | Chief Auditor | 2026 |
| Former (1) | ||
SP Chief Auditor | Chief Auditor | 2025 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Svenska Rehabiliterings Sjukhus Aktiebolag
Norpa AB Board members of Norpa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Patric Hofréus | Chief Auditor | 0 companies |
| Erik Gunnar Hansson | Chief Auditor | 0 companies |
| Tilda Louise Thu Ha Brune | Deputy Board Member | 0 companies |
| Anne Christine Wennerås | Deputy Board Member | 0 companies |
| Annika Elisabet Durgé Alström | Deputy Board Member | 0 companies |
| Lars Tage Oscar Brune | Board of Directors | 0 companies |